The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
School of Traditional Chinese Medicine, Naval Medical University, Shanghai, 200433, China.
BMC Complement Med Ther. 2023 Mar 30;23(1):97. doi: 10.1186/s12906-023-03922-z.
The Coronavirus Disease 2019 (COVID-19) has brought severe damage to global health and socioeconomics. In China, traditional Chinese medicine (TCM) is the most important complementary and alternative medicine (CAM) and it has shown a beneficial role in the prevention and treatment of COVID-19. However, it is unknown whether patients are willing to accept TCM treatment. The objective of our study is to investigate the acceptance, attitude, and independent predictors of TCM among asymptomatic COVID-19 patients admitted to Shanghai fangcang hospital during the outbreak of the COVID-19 pandemic in Shanghai in 2022.
A cross-sectional study was conducted on asymptomatic COVID-19 patients in the largest fangcang hospital in Shanghai, China, from April 22, 2022, to May 25, 2022. Based on the literature review of previous similar studies, a self-report questionnaire was developed to assess the patients' attitude and acceptance of TCM, and a multivariate logistic regression analysis was conducted to determine the independent predictors of TCM acceptance.
A total of 1,121 patients completed the survey, of whom 91.35% were willing to accept CAM treatment whereas 8.65% of participants showed no willingness. Multivariate logistic regression analysis revealed that the patients who have received two doses of COVID-19 vaccine (OR = 2.069, 95%CI: 1.029-4.162, P = 0.041 vs. not received), understood the culture of TCM (OR = 2.293, 95%CI: 1.029-4.162, P = 0.014 vs. not understood), thought the TCM treatment is safe (OR = 2.856, 95%CI: 1.334-6.112, P = 0.007 vs. not thought), thought the TCM treatment is effective (OR = 2.724, 95%CI: 1.249-5.940, P = 0.012 vs. not thought), and those who informed their attending physician if using TCM for treatment (OR = 3.455, 95%CI:1.867-6.392, P < 0.001 vs. not informed) were more likely to accept TCM treatment. However, patients who thought TCM might delay your treatment (OR = 0.256, 95%CI: 0.142-0.462, P < 0.001 not thought) was an independent predictor for unwillingness to accept TCM treatment.
This study preliminarily investigated the acceptance, attitude, and predictors of intention to receive TCM among asymptomatic COVID-19 patients. It is recommended to increase the publicity of TCM, clarify the impact of TCM and communicate with attending doctors that meet the healthcare needs of asymptomatic COVID-19 patients.
2019 年冠状病毒病（COVID-19）对全球健康和社会经济造成了严重破坏。在中国，中医药是最重要的补充和替代医学（CAM），并已显示出在 COVID-19 的预防和治疗方面的有益作用。然而，尚不清楚患者是否愿意接受中医药治疗。我们的研究目的是调查在 2022 年上海 COVID-19 大流行期间，在上海最大的方舱医院接受治疗的无症状 COVID-19 患者对中医药的接受程度、态度和独立预测因素。
我们于 2022 年 4 月 22 日至 5 月 25 日，对中国上海最大方舱医院的无症状 COVID-19 患者进行了一项横断面研究。基于对先前类似研究的文献回顾，我们开发了一份自我报告问卷，以评估患者对中医药的态度和接受程度，并进行了多变量逻辑回归分析，以确定中医药接受程度的独立预测因素。
共有 1121 名患者完成了调查，其中 91.35%表示愿意接受 CAM 治疗，而 8.65%的参与者表示不愿意。多变量逻辑回归分析显示，接受了两剂 COVID-19 疫苗（OR=2.069，95%CI：1.029-4.162，P=0.041 与未接种）、了解中医药文化（OR=2.293，95%CI：1.029-4.162，P=0.014 与不了解）、认为中医药治疗安全（OR=2.856，95%CI：1.334-6.112，P=0.007 与不认为）、认为中医药治疗有效（OR=2.724，95%CI：1.249-5.940，P=0.012 与不认为）、并告知主治医生如果使用中医药治疗（OR=3.455，95%CI：1.867-6.392，P<0.001 与未告知）的患者更有可能接受中医药治疗。然而，认为中医药可能会延误治疗（OR=0.256，95%CI：0.142-0.462，P<0.001 不认为）是不愿意接受中医药治疗的独立预测因素。
本研究初步调查了无症状 COVID-19 患者对中医药的接受程度、态度和接受意愿的预测因素。建议增加中医药宣传，明确中医药的影响并与主治医生沟通，以满足无症状 COVID-19 患者的医疗需求。
